Systematic identification of immunodominant CD8+ T-cell responses to influenza A virus in HLA-A2 individuals

Proceedings of the National Academy of Sciences of the United States of America

Volumn 108, Issue 22, 2011, Pages 9178-9183

  Wu, Chao ^a,b   Zanker, Damien ^b   Valkenburg, Sophie ^c   Tan, Bee ^b   Kedzierska, Katherine ^c   Zou, Quan Ming ^a   Doherty, Peter C ^c   Chen, Weisan ^b  

^a THIRD MILITARY MEDICAL UNIVERSITY   (China)

^b LUDWIG INSTITUTE FOR CANCER RESEARCH   (Australia)

^c UNIVERSITY OF MELBOURNE   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

HLA A2 ANTIGEN; INFLUENZA MATRIX PROTEIN 1 EPITOPE; UNCLASSIFIED DRUG; VIRUS ANTIGEN; VIRUS NUCLEOPROTEIN;

ANTIGEN DETECTION; ARTICLE; BINDING AFFINITY; CD8+ T LYMPHOCYTE; CELL SPECIFICITY; CELLULAR IMMUNITY; EX VIVO STUDY; HUMAN; INFLUENZA VIRUS A; NONHUMAN; NORMAL HUMAN; PRIORITY JOURNAL; PROTEIN MOTIF;

CD8-POSITIVE T-LYMPHOCYTES; COMPUTATIONAL BIOLOGY; EPITOPES; EPITOPES, T-LYMPHOCYTE; HLA-A2 ANTIGEN; HUMANS; IMMUNODOMINANT EPITOPES; IMMUNOTHERAPY; INFLUENZA A VIRUS; INTERFERON-GAMMA; LEUKOCYTES, MONONUCLEAR; NUCLEOPROTEINS; ORTHOMYXOVIRIDAE; PEPTIDES; VIRUSES;

INFLUENZA A VIRUS;

EID: 79959334212     PISSN: 00278424     EISSN: 10916490     Source Type: Journal    
DOI: 10.1073/pnas.1105624108     Document Type: Article

References (32)

1. Rimmelzwaan GF, et al. (2000) A randomized, double blind study in young healthy adults comparing cell mediated and humoral immune responses induced by influenza ISCOM vaccines and conventional vaccines. Vaccine 19:1180-1187. (Pubitemid 32010699)
2. Oukka M, et al. (1996) Protection against lethal viral infection by vaccination with nonimmunodominant peptides. J Immunol 157:3039-3045. (Pubitemid 126450063)
3. Christensen JP, Doherty PC, Branum KC, Riberdy JM (2000) Profound protection against respiratory challenge with a lethal H7N7 influenza A virus by increasing the magnitude of CD8(+) T-cell memory. J Virol 74:11690-11696. (Pubitemid 32222318)
4. McElhaney JE, et al. (2006) T cell responses are better correlates of vaccine protection in the elderly. J Immunol 176:6333-6339.
5. Bui HH, Peters B, Assarsson E, Mbawuike I, Sette A (2007) Ab and T cell epitopes of influenza A virus, knowledge and opportunities. Proc Natl Acad Sci USA 104:246-251. (Pubitemid 46068017)
6. Assarsson E, et al. (2008) Immunomic analysis of the repertoire of T-cell specificities for influenza A virus in humans. J Virol 82:12241-12251.
7. Flynn KJ, et al. (1998) Virus-specific CD8+ T cells in primary and secondary influenza pneumonia. Immunity 8:683-691. (Pubitemid 28294515)
8. Belz GT, Altman JD, Doherty PC (1998) Characteristics of virus-specific CD8(+) T cells in the liver during the control and resolution phases of influenza pneumonia. Proc Natl Acad Sci USA 95:13812-13817. (Pubitemid 28523055)
9. McMichael AJ, Gotch FM, Rothbard J (1986) HLA B37 determines an influenza A virus nucleoprotein epitope recognized by cytotoxic T lymphocytes. J Exp Med 164:1397-1406. (Pubitemid 17184177)
10. Boon AC, et al. (2002) The magnitude and specificity of influenza A virus-specific cytotoxic T-lymphocyte responses in humans is related to HLA-A and -B phenotype. J Virol 76:582-590. (Pubitemid 34033357)
11. Leslie AJ, et al. (2004) HIV evolution: CTL escape mutation and reversion after transmission. Nat Med 10:282-289. (Pubitemid 38667619)
12. Ammaranond P, et al. (2005) A new variant cytotoxic T lymphocyte escape mutation in HLA-B27-positive individuals infected with HIV type 1. AIDS Res Hum Retroviruses 21:395-397. (Pubitemid 40800455)
13. Eklund AC, Belchak MM, Lapidos K, Raha-Chowdhury R, Ober C (2000) Polymorphisms in the HLA-linked olfactory receptor genes in the Hutterites. Hum Immunol 61:711-717. (Pubitemid 30452565)
14. Goulder PJ, Watkins DI (2008) Impact of MHC class I diversity on immune control of immunodeficiency virus replication. Nat Rev Immunol 8:619-630.
15. Burrows SR, Rossjohn J, McCluskey J (2006) Have we cut ourselves too short in mapping CTL epitopes? Trends Immunol 27:11-16.
16. Ebert LM, et al. (2009) A long, naturally presented immunodominant epitope from NY-ESO-1 tumor antigen: Implications for cancer vaccine design. Cancer Res 69:1046-1054.
17. Chen W, et al. (2001) A novel influenza A virus mitochondrial protein that induces cell death. Nat Med 7:1306-1312. (Pubitemid 34007934)
18. Schumacher TN, et al. (1991) Peptide selection by MHC class I molecules. Nature 350:703-706. (Pubitemid 21912301)
19. Kozlowski S, et al. (1993) Multiple pathways are involved in the extracellular processing of MHC class I-restricted peptides. J Immunol 151:4033-4044. (Pubitemid 23298736)
20. Zemmour J, Little AM, Schendel DJ, Parham P (1992) The HLA-A,B "negative" mutant cell line C1R expresses a novel HLA-B35 allele, which also has a point mutation in the translation initiation codon. J Immunol 148:1941-1948.
21. DiBrino M, et al. (1993) HLA-A1 and HLA-A3 T cell epitopes derived from influenza virus proteins predicted from peptide binding motifs. J Immunol 151:5930-5935. (Pubitemid 23340338)
22. Suhrbier A, Schmidt C, Fernan A (1993) Prediction of an HLA B8-restricted influenza epitope by motif. Immunology 79:171-173. (Pubitemid 23151211)
23. Boon AC, et al. (2004) Preferential HLA usage in the influenza virus-specific CTL response. J Immunol 172:4435-4443. (Pubitemid 38375259)
24. Lee LY, et al. (2008) Memory T cells established by seasonal human influenza A infection cross-react with avian influenza A (H5N1) in healthy individuals. J Clin Invest 118:3478-3490.
25. Wahl A, et al. (2009) HLA class I molecules consistently present internal influenza epitopes. Proc Natl Acad Sci USA 106:540-545.
26. Townsend AR, McMichael AJ, Carter NP, Huddleston JA, Brownlee GG (1984) Cytotoxic T cell recognition of the influenza nucleoprotein and hemagglutinin expressed in transfected mouse L cells. Cell 39:13-25. (Pubitemid 15218221)
27. Kreijtz JH, et al. (2008) Cross-recognition of avian H5N1 influenza virus by human cytotoxic T-lymphocyte populations directed to human influenza A virus. J Virol 82:5161-5166. (Pubitemid 351705225)
28. Shaw ML, Stone KL, Colangelo CM, Gulcicek EE, Palese P (2008) Cellular proteins in influenza virus particles. PLoS Pathog 4:e1000085.
29. Moutaftsi M, et al. (2006) A consensus epitope prediction approach identifies the breadth of murine T(CD8+)-cell responses to vaccinia virus. Nat Biotechnol 24:817-819. (Pubitemid 44086622)
30. Yuen TJ, et al. (2010) Analysis of A47, an immunoprevalent protein of vaccinia virus, leads to a reevaluation of the total antiviral CD8+ T cell response. J Virol 84:10220-10229.
31. Touvrey C, et al. (2009) Dominant human CD8 T cell clonotypes persist simultaneously as memory and effector cells in memory phase. J Immunol 182:6718-6726.
32. Rimmelzwaan GF, Kreijtz JH, Bodewes R, Fouchier RA, Osterhaus AD (2009) Influenza virus CTL epitopes, remarkably conserved and remarkably variable. Vaccine 27:6363-6365.